Am J Perinatol
DOI: 10.1055/a-2334-6990
SMFM Fellowship Series Article

Hemoglobin Electrophoresis versus Kleihauer–Betke to Determine Bone Marrow Suppression in Fetuses Undergoing Intrauterine Transfusion

1   Department of Women's Health, University of Texas at Austin, Dell Medical School, Austin, Texas
,
Erin Moise
1   Department of Women's Health, University of Texas at Austin, Dell Medical School, Austin, Texas
2   Comprehensive Fetal Care Center, Dell Children's Medical Center, Austin, Texas
,
Mark Nwokocha
2   Comprehensive Fetal Care Center, Dell Children's Medical Center, Austin, Texas
,
Michael Bebbington
1   Department of Women's Health, University of Texas at Austin, Dell Medical School, Austin, Texas
2   Comprehensive Fetal Care Center, Dell Children's Medical Center, Austin, Texas
,
1   Department of Women's Health, University of Texas at Austin, Dell Medical School, Austin, Texas
2   Comprehensive Fetal Care Center, Dell Children's Medical Center, Austin, Texas
› Author Affiliations
Funding None.

Abstract

Objective Mainstay therapy for fetuses affected by maternal red cell alloimmunization is serial intrauterine transfusion (IUT). Testing to determine when fetal red cells have been replaced with donor cells historically involves the use of the Kleihauer–Betke (KB) test. Hemoglobin (Hgb) electrophoresis testing may be more rapid with a reduced cost of analysis. We aimed to determine the correlation between fetal Hgb electrophoresis versus the traditional KB test.

Study Design This is a retrospective analysis of all alloimmunized singleton pregnancies undergoing IUT between January 1, 2021, and July 1, 2023. Maternal and fetal characteristics were collected along with the indication for IUT. A final fetal blood sample was obtained at the conclusion of each transfusion and sent for KB testing and Hgb electrophoresis. The primary outcome was the assessment of these parameters in their ability to predict the replacement of the fetal circulating red cell population with donor cells. Linear regression analysis and repeated measures analysis of variance were performed, and p-values less than 0.05 were considered significant.

Results A total of 56 IUTs were performed in 16 patients. There were 39 (69.6%) final KB test values collected and compared with 30 (53.6%) final Hgb electrophoresis values. Hgb electrophoresis when compared with the KB test demonstrated a significant correlation (R 2 = 0.93; 95% confidence interval, 0.61–0.76; p < 0.001). This same finding held true when examining the correlation at each individual IUT as well. The final KB test and Hgb electrophoresis values significantly decreased with each transfusion (p = 0.003). A predominance of adult donor blood was noted by the third transfusion for both laboratory indices.

Conclusion Fetal Hgb electrophoresis obtained at the time of IUT demonstrates a significant correlation with the traditional KB test.

Key Points

  • Fetal Hgb electrophoresis following IUT is underexplored

  • Hgb electrophoresis is an automated evaluation

  • The traditional KB test is a manual evaluation

  • These two tests demonstrate significant correlation

Note

Presented as a poster at the 44th annual meeting of the Society for Maternal-Fetal Medicine, National Harbor, MD, February 14, 2024.




Publication History

Received: 24 January 2024

Accepted: 27 May 2024

Accepted Manuscript online:
28 May 2024

Article published online:
18 June 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Mari G, Norton ME, Stone J. et al; Society for Maternal-Fetal Medicine (SMFM). Electronic address: pubs@smfm.org. Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: the fetus at risk for anemia—diagnosis and management. Am J Obstet Gynecol 2015; 212 (06) 697-710
  • 2 Yu D, Ling LE, Krumme AA, Tjoa ML, Moise Jr KJ. Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010. AJOG Glob Rep 2023; 3 (02) 100203
  • 3 Moise KJ. Fetal anemia due to non-Rhesus-D red-cell alloimmunization. Semin Fetal Neonatal Med 2008; 13 (04) 207-214
  • 4 Liley AW. Liquor amnil analysis in the management of the pregnancy complicated by resus sensitization. Am J Obstet Gynecol 1961; 82: 1359-1370
  • 5 Liley AW. Errors in the assessment of hemolytic disease from amniotic fluid. Am J Obstet Gynecol 1963; 86: 485-494
  • 6 Mari G, Deter RL, Carpenter RL. et al; Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. N Engl J Med 2000; 342 (01) 9-14
  • 7 Zwiers C, Oepkes D, Lopriore E, Klumper FJ, de Haas M, van Kamp IL. The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization. Prenat Diagn 2018; 38 (12) 943-950
  • 8 de Winter DP, Kaminski A, Tjoa ML, Oepkes D. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape. BMC Pregnancy Childbirth 2023; 23 (01) 12
  • 9 Goodrum LA, Saade GR, Belfort MA, Carpenter Jr RJ, Moise Jr KJ. The effect of intrauterine transfusion on fetal bilirubin in red cell alloimmunization. Obstet Gynecol 1997; 89 (01) 57-60
  • 10 Saade GR, Moise KJ, Belfort MA, Hesketh DE, Carpenter RJ. Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions. Fetal Diagn Ther 1993; 8 (03) 161-164
  • 11 Ree IMC, Lopriore E, Zwiers C. et al. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions. Am J Obstet Gynecol 2020; 223 (01) 119.e1-119.e10
  • 12 Hematological Disorders. In: Cunningham F, Leveno KJ, Dashe JS, Hoffman BL, Spong CY, Casey BM. eds. Williams Obstetrics, 26e. McGraw Hill; 2022. Accessed October 03, 2023 at: https://accessmedicine-mhmedical-com.ezproxy.lib.utexas.edu/content.aspx?bookid=2977&sectionid=257227392
  • 13 Chernecky CC, Berger BJ. Betke-Kleihauer stain (fetal hemoglobin stain, Kleihauer-Betke stain, K-B) diagnostic. In: Chernecky CC, Berger BJ. eds. Laboratory Tests and Diagnostic Procedures. 6th ed.. St Louis, MO: Elsevier Saunders; 2013: 193-194
  • 14 Cooling L, Downs T. Immunohematology. In: McPherson RA, Pincus MR. eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. 23rd ed.. St Louis, MO: Elsevier; 2017. chap 35
  • 15 FindLabTest.com. Kleihauer-Betke Stain (test), Hemoglobinopathy Evaluation (test). Accessed October 10, 2023 at: https://www.findlabtest.com/lab-test/search?q=qt34942+qt35489
  • 16 UTMB Health Laboratory Test Directory. Hemoglobinopathy Evaluation (LAB002057), Fetal Hemoglobin Stain (10005291). Accessed October 10, 2023 at: https://www.utmb.edu/lsg2/Home/Details?id=1368
  • 17 Moise Jr KJ, Carpenter Jr RJ, Kirshon B, Deter RL, Sala JD, Cano LE. Comparison of four types of intrauterine transfusion: effect on fetal hematocrit. Fetal Ther 1989; 4 (2–3): 126-137
  • 18 Giannina G, Moise Jr. KJ, Dorman K. A simple method to estimate volume for fetal intravascular transfusions. Fetal Diagn Ther 1998; 13 (02) 94-97
  • 19 Sobhani NC, Zakieh A, Bakhtary S, Gonzalez JM. Intrauterine transfusion practice patterns in the United States. Am J Obstet Gynecol MFM 2022; 4 (04) 100655
  • 20 Birkmeyer JD, Dimick JB. Understanding and reducing variation in surgical mortality. Annu Rev Med 2009; 60: 405-415